Toll-like receptor 4 in experimental kidney transplantation: Early mediator of endogenous danger signals

Nephron - Experimental Nephrology

Volumn 121, Issue 3-4, 2013, Pages

  Bergler, Tobias ^a   Hoffmann, Ute ^a,b   Bergler, Elisabeth ^a   Jung, Bettina ^a   Banas, Miriam C ^a   Reinhold, Stephan W ^a   Krämer, Bernhard K ^c   Banas, Bernhard ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b KRANKENHAUS BARMHERZIGE BRÜDER   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Allogeneic kidney transplantation; Chemokines; Fibrinogen; Innate immunity; Macrophages

Indexed keywords

BETA CHEMOKINE; CD20 ANTIGEN; CD3 ANTIGEN; CD68 ANTIGEN; CHEMOKINE RECEPTOR CCR6; CREATININE; FIBRINOGEN; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE RELEASE; IMMUNOHISTOCHEMISTRY; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; UPREGULATION;

ANIMALS; BIOLOGICAL MARKERS; KIDNEY TRANSPLANTATION; MALE; MODELS, ANIMAL; RATS; RATS, INBRED BN; RATS, INBRED LEW; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TRANSPLANTATION, HOMOLOGOUS;

EID: 84869205106     PISSN: None     EISSN: 16602129     Source Type: Journal    
DOI: 10.1159/000343566     Document Type: Article

References (55)

1. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Yamaguchi Y: The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723. (Pubitemid 29082898)
2. el-Sawy T, Fahmy NM, Fairchild RL: Chemokines: directing leukocyte infiltration into allografts. Curr Opin Immunol 2002; 14: 562-568.
3. Colvin BL, Thomson AW: Chemokines, their receptors, and transplant outcome. Transplantation 2002; 74: 149-155. (Pubitemid 34810278)
4. Hancock WW, Wang L, Ye Q, Han R, Lee I: Chemokines and their receptors as markers of allograft rejection and targets for immunosuppression. Curr Opin Immunol 2003; 15: 479-486. (Pubitemid 37130185)
5. Segerer S, Nelson PJ, Schlöndorff D: Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 2000; 11: 152-176. (Pubitemid 30020438)
6. Hertz CJ, Wu Q, Porter EM, Zhang YJ, Weismuller KH, Godowski PJ, Ganz T, Randell SH, Modlin RL: Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2. J Immunol 2003; 171: 6820-6826. (Pubitemid 37532117)
7. Iwasaki A, Medzhitov R: Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004; 5: 987-995. (Pubitemid 41057715)
8. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R: Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118: 229-241. (Pubitemid 38962578)
9. Schnare M, Barton GM, Holt AC, Takeda K, Akira S, Medzhitov R: Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001; 2: 947-950. (Pubitemid 32976167)
10. Akira S, Takeda K: Functions of toll-like receptors: lessons from KO mice. C R Biol 2004; 327: 581-589. (Pubitemid 38979508)
11. Anders HJ, Banas B, Schlöndorff D: Signaling danger: toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol 2004; 15: 854-867. (Pubitemid 38375304)
12. Beg AA: Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol 2002; 23: 509-512. (Pubitemid 35223541)
13. Wallin RP, Lundqvist A, More SH, von BA, Kiessling R, Ljunggren HG: Heat-shock proteins as activators of the innate immune system. Trends Immunol 2002; 23: 130-135. (Pubitemid 34178294)
14. Friedland JS, Shattock R, Remick DG, Griffin GE: Mycobacterial 65-kD heat shock protein induces release of proinflammatory cytokines from human monocytic cells. Clin Exp Immunol 1993; 91: 58-62. (Pubitemid 23027998)
15. Retzlaff C, Yamamoto Y, Hoffman PS, Friedman H, Klein TW: Bacterial heat shock proteins directly induce cytokine mRNA and interleukin-1 secretion in macrophage cultures. Infect Immun 1994; 62: 5689-5693. (Pubitemid 24365021)
16. Tsan MF, Gao B: Endogenous ligands of Tolllike receptors. J Leukoc Biol 2004; 76: 514-519.
17. Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, Chow JC, Strauss JF III: The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 2001; 276: 10229-10233.
18. Saito S, Yamaji N, Yasunaga K, Saito T, Matsumoto S, Katoh M, Kobayashi S, Masuho Y: The fibronectin extra domain A activates matrix metalloproteinase gene expression by an interleukin-1-dependent mechanism. J Biol Chem 1999; 274: 30756-30763.
19. Noble PW, McKee CM, Cowman M, Shin HS: Hyaluronan fragments activate an NFkappa B/I-kappa B alpha autoregulatory loop in murine macrophages. J Exp Med 1996; 183: 2373-2378. (Pubitemid 26158930)
20. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC: Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002; 195: 99-111. (Pubitemid 34074500)
21. Termeer CC, Hennies J, Voith U, Ahrens T, Weiss JM, Prehm P, Simon JC: Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol 2000; 165: 1863-1870. (Pubitemid 30643136)
22. Smiley ST, King JA, Hancock WW: Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 2001; 167: 2887-2894. (Pubitemid 32768923)
23. Zhai Y, Qiao B, Shen XD, Gao F, Busuttil RW, Cheng G, Platt JL, Volk HD, Kupiec-Weglinski JW: Evidence for the pivotal role of endogenous toll-like receptor 4 ligands in liver ischemia and reperfusion injury. Transplantation 2008; 85: 1016-1022. (Pubitemid 351543166)
24. Wang S, Schmaderer C, Kiss E, Schmidt C, Bonrouhi M, Porubsky S, Gretz N, Schaefer L, Kirschning CJ, Popovic ZV, Grone HJ: Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88-and TRIF-dependent signaling. Dis Model Mech 2010; 3: 92-103.
25. Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, Eris JM, Alexander SI, Sharland AF, Chadban SJ: TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 2007; 117: 2847-2859. (Pubitemid 47529615)
26. Pulskens WP, Teske GJ, Butter LM, Roelofs JJ, van der PT, Florquin S, Leemans JC: Tolllike receptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury. PLoS One 2008; 3:e3596.
27. Pulskens WP, Rampanelli E, Teske GJ, Butter LM, Claessen N, Luirink IK, van der PT, Florquin S, Leemans JC: TLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury. J Am Soc Nephrol 2010; 21: 1299-1308.
28. Palmer SM, Burch LH, Mir S, Smith SR, Kuo PC, Herczyk WF, Reinsmoen NL, Schwartz DA: Donor polymorphisms in Toll-like receptor-4 influence the development of rejection after renal transplantation. Clin Transplant 2006; 20: 30-36. (Pubitemid 43349021)
29. Hwang YH, Ro H, Choi I, Kim H, Oh KH, Hwang JI, Park MH, Kim S, Yang J, Ahn C: Impact of polymorphisms of TLR4/CD14 and TLR3 on acute rejection in kidney transplantation. Transplantation 2009; 88: 699-705.
30. Hoffmann U, Bergler T, Rihm M, Pace C, Krüger B, Rümmele P, Stoelcker B, Banas B, Männel DN, Krämer BK: Upregulation of TNF receptor type 2 in human and experimental renal allograft rejection. Am J Transplant 2009; 9: 675-686.
31. Hoffmann U, Bergler T, Rihm M, Pace C, Krüger B, Jung B, Reinhold SW, Farkas S, Rümmele P, Krämer BK, Banas B: Impact of Toll-like receptor 2 expression in renal allograft rejection. Nephrol Dial Transplant 2011; 26: 1080-1087.
32. Hoffmann U, Segerer S, Rümmele P, Krüger B, Pietrzyk M, Hofstadter F, Banas B, Krämer BK: Expression of the chemokine receptor CXCR3 in human renal allografts-a prospective study. Nephrol Dial Transplant 2006; 21: 1373-1381.
33. Tsuboi N, Yoshikai Y, Matsuo S, Kikuchi T, Iwami K, Nagai Y, Takeuchi O, Akira S, Matsuguchi T: Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol 2002; 169: 2026-2033. (Pubitemid 34857667)
34. Leemans JC, Stokman G, Claessen N, Rouschop KM, Teske GJ, Kirschning CJ, Akira S, van der PT, Weening JJ, Florquin S: Renalassociated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 2005; 115: 2894-2903. (Pubitemid 41434417)
35. Wang H, Li ZY, Wu HS, Wang Y, Jiang CF, Zheng QC, Zhang JX: Endogenous danger signals trigger hepatic ischemia/reperfusion injury through toll-like receptor 4/nuclear factor-kappa B pathway. Chin Med J (Engl) 2007; 120: 509-514. (Pubitemid 46510764)
36. Wu HS, Zhang JX, Wang L, Tian Y, Wang H, Rotstein O: Toll-like receptor 4 involvement in hepatic ischemia/reperfusion injury in mice. Hepatobiliary Pancreat Dis Int 2004; 3: 250-253. (Pubitemid 38660160)
37. Laudanna C, Kim JY, Constantin G, Butcher E: Rapid leukocyte integrin activation by chemokines. Immunol Rev 2002; 186: 37-46.
38. Fischereder M: Chemokines and chemokine receptors in renal transplantation-from bench to bedside. Acta Physiol Hung 2007; 94: 67-81.
39. Krüger B, Böger CA, Obed A, Farkas S, Hoffmann U, Banas B, Fischereder M, Krämer BK: RANTES/CCL5 polymorphisms as a risk factor for recurrent acute rejection. Clin Transplant 2007; 21: 385-390. (Pubitemid 46711402)
40. Ruster M, Sperschneider H, Funfstuck R, Stein G, Grone HJ: Differential expression of beta-chemokines MCP-1 and RANTES and their receptors CCR1, CCR2, CCR5 in acute rejection and chronic allograft nephropathy of human renal allografts. Clin Nephrol 2004; 61: 30-39. (Pubitemid 38100841)
41. Schröppel B, Zhang N, Chen P, Chen D, Bromberg JS, Murphy B: Role of donor-derived monocyte chemoattractant protein-1 in murine islet transplantation. J Am Soc Nephrol 2005; 16: 444-451. (Pubitemid 41725140)
42. Grandaliano G, Gesualdo L, Ranieri E, Monno R, Stallone G, Schena FP: Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection. Transplantation 1997; 63: 414-420. (Pubitemid 27086035)
43. Woltman AM, de Fijter JW, van der Kooij SW, Jie KE, Massacrier C, Caux C, Daha MR, van KC: MIP-3alpha/CCL20 in renal transplantation and its possible involvement as dendritic cell chemoattractant in allograft rejection. Am J Transplant 2005; 5: 2114-2125. (Pubitemid 41648458)
44. Dubinski B, Boratynska M, Kopec W, Szyber P, Patrzalek D, Klinger M: Activated cells in urine and monocyte chemotactic peptide-1 (MCP-1)-sensitive rejection markers in renal graft recipients. Transpl Immunol 2008; 18: 203-207. (Pubitemid 350151854)
45. de Groot K, Kuklik K, Bröcker V, Schwarz A, Gwinner W, Kreipe H, Haller H, Fliser D, Mengel M: Toll-like receptor 2 and renal allograft function. Am J Nephrol 2008; 28: 583-588. (Pubitemid 351832445)
46. Deng JF, Geng L, Qian YG, Li H, Wang Y, Xie HY, Feng XW, Zheng SS: The role of toll-like receptors 2 and 4 in acute allograft rejection after liver transplantation. Transplant Proc 2007; 39: 3222-3224. (Pubitemid 350251413)
47. Banas MC, Banas B, Hudkins KL, Wietecha TA, Iyoda M, Bock E, Hauser P, Pippin JW, Shankland SJ, Smith KD, Stoelcker B, Liu G, Grone HJ, Kramer BK, Alpers CE: TLR4 links podocytes with the innate immune system to mediate glomerular injury. J Am Soc Nephrol 2008; 19: 704-713.
48. Ning Q, Sun Y, Han M, Zhang L, Zhu C, Zhang W, Guo H, Li J, Yan W, Gong F, Chen Z, He W, Koscik C, Smith R, Gorczynski R, Levy G, Luo X: Role of fibrinogen-like protein prothrombinase/fibroleukin in experimental and human allograft rejection. J Immunol 2005; 174: 7403-7411. (Pubitemid 40705712)
49. Krüger B, Krick S, Dhillon N, Lerner SM, Ames S, Bromberg JS, Lin M, Walsh L, Vella J, Fischereder M, Krämer BK, Colvin RB, Heeger PS, Murphy BT, Schröppel B: Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci USA 2009; 106: 3390-3395.
50. Chen A, Sheu LF, Ho YS, Lin YF, Chou WY, Chou TC, Lee WH: Experimental focal segmental glomerulosclerosis in mice. Nephron 1998; 78: 440-452. (Pubitemid 28154166)
51. Cunningham MA, Ono T, Hewitson TD, Tipping PG, Becker GJ, Holdsworth SR: Tissue factor pathway inhibitor expression in human crescentic glomerulonephritis. Kidney Int 1999; 55: 1311-1318. (Pubitemid 29157129)
52. Cunningham MA, Kitching AR, Tipping PG, Holdsworth SR: Fibrin independent proinflammatory effects of tissue factor in experimental crescentic glomerulonephritis. Kidney Int 2004; 66: 647-654. (Pubitemid 38982007)
53. Lai PC, Smith J, Bhangal G, Chaudhry KA, Chaudhry AN, Keith JC Jr, Tam FW, Pusey CD, Cook HT: Interleukin-11 reduces renal injury and glomerular NF-kappa B activity in murine experimental glomerulonephritis. Nephron Exp Nephrol 2005; 101:e146-e154.
54. He H, Stone JR, Perkins DL: Analysis of robust innate immune response after transplantation in the absence of adaptive immunity. Transplantation 2002; 73: 853-861. (Pubitemid 34252345)
55. Christopher K, Mueller TF, Ma C, Liang Y, Perkins DL: Analysis of the innate and adaptive phases of allograft rejection by cluster analysis of transcriptional profiles. J Immunol 2002; 169: 522-530. (Pubitemid 34686175)